EuropaBio and Alexion: RARE Conversations (Take Two) Keeping Rare Disease Patients In The Centre Of Discussion

On February 4th, Alexion continued its RareConversations event series in cooperation with EuropaBio.

Measuring the economic footprint of the Biotechnology Industry in Europe (WifOR Study)

The purpose of this study is to estimate the economic impact of the production activities of European enterprises applying biotechnology in their research and manufacturing processes.

Industrial biotechnology solutions for sustainable agriculture

Read our new report on industrial biotech solutions that support the objectives of the CAP revision programme.

EuropaBio Patients BioForum – Key Messages

Read the key recommendations of the EuropaBio Patients BioForum to the new EU institutions.

Vision for a Circular Bio-Society

BIC and fifteen organisations set out joint Vision for Europe’s bioeconomy future – a circular bio-society.

Industrial biotechnology – Contributing towards achieving the UN global Sustainable Development Goals

The economic impact of the biotech sector today and beyond.

From Patent to Patient – The importance of IP rewards and incentives

The system of IP rewards and incentives exists and works together to allow adequate time for the companies and investors to recoup their years of investment and fully realise clinical value before their inventions become part of the public domain and can be used by others.

“Buying Innovative” in the Healthcare Biotech Market in Europe

This paper proposes key steps to consider when purchasing biological medicines, looking at each stage of the procurement process.

Jobs & Growth Generated by Industrial Biotechnology in Europe

The economic impact of the biotech sector today and beyond.